Skip to Content

First Trust Nasdaq Pharmaceuticals ETF FTXH

Medalist Rating as of | See First Trust Investment Hub

Morningstar’s Analysis FTXH

Will FTXH outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit First Trust Nasdaq Pharmaceuticals ETF to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FTXH

  • Current Portfolio Date
  • Equity Holdings 50
  • Bond Holdings 0
  • Other Holdings 1
  • % Assets in Top 10 Holdings 55.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector
7.46
1,513,014
Healthcare
7.45
1,510,260
Healthcare
7.32
1,484,393
Healthcare
6.29
1,274,266
Healthcare
6.16
1,248,300
Healthcare
4.67
947,367
Healthcare
4.04
818,438
Healthcare
4.01
813,510
Healthcare
3.89
788,570
Healthcare
3.82
774,892
Healthcare